Full cohort |
Crude |
Step1*
|
Step2**
|
Step3***
|
|
Beta [95% CI] |
Beta [95% CI] |
Beta [95% CI] |
Beta
[95% CI] |
No Anxiety |
0 [Reference] |
0 [Reference] |
0 [Reference] |
0 [Reference] |
Week 17 |
-55.8 [-78.3, -33.2] |
-53.8 [-79.3,
-28.3] |
-28.5 [-53.3, -3.8] |
-26.9 [-52.7,
-1.2] |
Week 30 |
-78.8 [-102.5, -55.1] |
-63.9 [-90.9,
-36.9] |
-38 [-64.2, -11.8] |
-34.5 [-61.7,
-7.3] |
Both |
-112.8 [-142.7, -83] |
-95.1 [-128.9,
-61.2] |
-56.3 [-89.1, -23.4] |
-54.2 [-88.4,
-20.1] |
Sample size |
88,904 |
73,014 |
73,014 |
69,430 |
Sibling cohort |
|
|
|
|
No Anxiety |
0 [Reference] |
0 [Reference] |
0 [Reference] |
0 [Reference] |
Week 17 |
-92.1 [-150.8, -33.5] |
-102.5 [-173.4,
-31.6] |
-0.4 [-68.5, 67.7] |
-3.7 [-75.6,
68.3] |
Week 30 |
-115.1 [-175.8, -54.3] |
-118.8
[-193.5, -44] |
-13 [-84.9, 58.9] |
-14.1 [-90.1,
62] |
Both |
-173.9 [-252.3, -95.4] |
-185.4 [-281.1,
-89.7] |
-24.2 [-116.5, 68] |
-31.1 [-128.5,
66.3] |
Sample size1
|
12,080 |
8,937 |
8,937 |
8,298 |